Active, Not Recruiting
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)
NCT05655013
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark